Search - tctmd.com

Displaying 361 - 380 of 1576

Sort: Relevancy | Date

Presentation TCT 2017

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Insights From the PCI Arms in EXCEL and NOBLE: Can the Outcomes Be Further Improved?

Presenter: Antonio Colombo, David E. Kandzari, Marie-Claude Morice

October 31, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Presentation TCT 2017

Master Perspectives: Compared to Medical Therapy, Does CTO PCI Improve Prognosis, or Are the Main Benefits Symptomatic Improvement?

Presenter: Barry D. Rutherford, Robert W. Yeh

October 31, 2017

Presentation TCT 2017

Insights From the PLATINUM DIVERSITY Study

Presenter: Alice K. Jacobs, Spencer B. King III, Wayne B. Batchelor

October 31, 2017

Presentation TCT 2017

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program

Presenter: Farouc Jaffer, Ajay J. Kirtane, Nicholas J. Lembo

October 31, 2017

Presentation TCT 2017

Case Presentation: No Reflow After Primary PCI

Presenter: David P. Faxon, Robert S. Schwartz, Mohamed Abdel-Wahab

October 31, 2017

Presentation TCT 2017

Insights From the CABG Arms in EXCEL and NOBLE: What Met Expectations, What Didnt?

Presenter: Antonio Colombo, David E. Kandzari, John D. Puskas

October 31, 2017

Presentation TCT 2017

Case #4: Paravalvular Leak Closure Using a Multifunctional Occluder Device

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Richard Nicandro R Torres

October 31, 2017

Presentation TCT 2017

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Presenter: David P. Faxon, Robert S. Schwartz, Stefan K. James

October 31, 2017

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Outcomes and Clinical Implications From EXPLORE

Presenter: Barry D. Rutherford, Robert W. Yeh, Jose P.S. Henriques

October 31, 2017

Presentation TCT 2017

Insights From New Meta-Analyses of PCI vs CABG for Left Main Revascularization

Presenter: Antonio Colombo, David E. Kandzari, Davide Capodanno

October 31, 2017

Presentation TCT 2017

Debate: Should CHIP Success Be Defined by Complete Revascularization? Con!

Presenter: Farouc Jaffer, Ajay J. Kirtane

October 31, 2017

Presentation TCT 2017

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

Presenter: David P. Faxon, Robert S. Schwartz, Raffaele Piccolo

October 31, 2017

Presentation TCT 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presenter: Azeem Latib, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

Ukraine Presents to Egypt: Complications During a CTO PCI

Presenter: Mohammad Al-Mutairi, Ahmed Magdy, Maxim Sokolov

October 31, 2017

Presentation TCT 2017

Outcomes and Clinical Implications From the Euro-CTO Trial

Presenter: Barry D. Rutherford, Robert W. Yeh, Gerald S. Werner

October 31, 2017

Presentation TCT 2017

NOBLE: Core Findings Revisited and New Data

Presenter: Antonio Colombo, David E. Kandzari, Evald H. Christiansen

October 31, 2017

Presentation TCT 2017

Debate: Should CHIP Success Be Defined by Complete Revascularization? Pro!

Presenter: Farouc Jaffer, Ajay J. Kirtane, William L. Lombardi

October 31, 2017

Advertisement

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Insights From the PCI Arms in EXCEL and NOBLE: Can the Outcomes Be Further Improved?

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Master Perspectives: Compared to Medical Therapy, Does CTO PCI Improve Prognosis, or Are the Main Benefits Symptomatic Improvement?

Insights From the PLATINUM DIVERSITY Study

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program

Case Presentation: No Reflow After Primary PCI

Insights From the CABG Arms in EXCEL and NOBLE: What Met Expectations, What Didnt?

Case #4: Paravalvular Leak Closure Using a Multifunctional Occluder Device

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Outcomes and Clinical Implications From EXPLORE

Insights From New Meta-Analyses of PCI vs CABG for Left Main Revascularization

Debate: Should CHIP Success Be Defined by Complete Revascularization? Con!

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Ukraine Presents to Egypt: Complications During a CTO PCI

Outcomes and Clinical Implications From the Euro-CTO Trial

NOBLE: Core Findings Revisited and New Data

Debate: Should CHIP Success Be Defined by Complete Revascularization? Pro!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content